miRNA as a potential biomarker for early breast cancer
One way to potentially improve long term cancer statistics is earlier detection, and in high risk patients, appropriate initiation of earlier treatment, since it is well known that the survival in stage II or III breast cancer is noticeably better than that for stage IV metastatic disease.
A critical question then, is how do we improve earlier detection?
There are a number of ways to achieve this:
- Imaging techniques
- Prognostication
- Diagnostics
- Biomarkers
Still, this was exactly the problem I was experiencing when researching the topic recently.